A detailed history of Morgan Stanley transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Morgan Stanley holds 162,819 shares of OLK stock, worth $4.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
162,819
Previous 17,484 831.25%
Holding current value
$4.23 Million
Previous $439,000 771.75%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.81 - $25.14 $3.17 Million - $3.65 Million
145,335 Added 831.25%
162,819 $3.83 Million
Q4 2023

Feb 13, 2024

BUY
$14.29 - $25.95 $180,139 - $327,125
12,606 Added 258.43%
17,484 $439,000
Q3 2023

Nov 15, 2023

SELL
$14.45 - $20.34 $260,923 - $367,279
-18,057 Reduced 78.73%
4,878 $71,000
Q2 2023

Aug 14, 2023

BUY
$17.13 - $23.74 $27,133 - $37,604
1,584 Added 7.42%
22,935 $430,000
Q1 2023

May 15, 2023

BUY
$19.34 - $24.11 $106,118 - $132,291
5,487 Added 34.59%
21,351 $481,000
Q4 2022

Feb 14, 2023

SELL
$12.64 - $25.52 $358,546 - $723,900
-28,366 Reduced 64.13%
15,864 $402,000
Q3 2022

Nov 14, 2022

BUY
$12.14 - $18.42 $336,193 - $510,105
27,693 Added 167.46%
44,230 $537,000
Q2 2022

Oct 27, 2022

BUY
$8.95 - $19.24 $146,466 - $314,862
16,365 Added 9514.53%
16,537 $252,000
Q2 2022

Aug 15, 2022

BUY
$8.95 - $19.24 $146,466 - $314,862
16,365 Added 9514.53%
16,537 $252,000
Q1 2022

Oct 27, 2022

SELL
$11.33 - $19.3 $185,415 - $315,844
-16,365 Reduced 98.96%
172 $3,000
Q1 2022

May 13, 2022

SELL
$11.33 - $19.3 $6.36 Million - $10.8 Million
-561,445 Reduced 99.97%
172 $3,000
Q4 2021

Feb 14, 2022

BUY
$18.0 - $34.82 $482,886 - $934,116
26,827 Added 5.02%
561,617 $10.2 Million
Q3 2021

Nov 15, 2021

BUY
$23.42 - $37.93 $12.5 Million - $20.3 Million
534,790 New
534,790 $13 Million

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Market Cap $3.1B
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.